Author Topic: Glatiramer acetate and liver injury research information (PubMed)  (Read 41 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8564
  • MS diagnosed 1980
  • Location: Pacific Northwest
PubMed has listed several studies  from a report called LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, done by the National Institute of Diabetes and Digestive and Kidney Diseases   on liver toxicity of various MS drugs.Each drug is rated on a likelihood scale--indicating how likely that drug is to cause liver toxicity problems. The rating for Copaxone is B. Here is the scale:


https://www.ncbi.nlm.nih.gov/books/NBK548392/


This is the material on Copaxone--and there are several sections. The Case Report and Overview sections might be particularly useful.


https://www.ncbi.nlm.nih.gov/pubmed/31644036


I will be posting similar information for other MS drugs (from the same source) soon.



MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
24 Views
Last post October 25, 2019, 07:56:09 pm
by agate
0 Replies
57 Views
Last post October 26, 2019, 03:31:32 pm
by agate
0 Replies
28 Views
Last post October 26, 2019, 03:36:52 pm
by agate
0 Replies
40 Views
Last post October 26, 2019, 03:38:12 pm
by agate
0 Replies
44 Views
Last post October 28, 2019, 04:12:17 pm
by agate